Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. has demonstrated robust financial performance highlighted by a rental rate growth of 4.1% year-over-year and exceptional same-store NOI growth of 25.3% in its SHOP segment and 21.7% in ISHC. The company has achieved the highest funds from operations (FFO) growth rate within the Healthcare REIT sector, attributed to effective internal and external strategies that align with favorable industry trends. With a strengthened cost of capital since late 2024, AHR is well-positioned for aggressive and accretive capital deployments, further bolstering its long-term organic growth potential.

Bears say

American Healthcare REIT Inc. has demonstrated a decrease in leverage, with net debt to gross asset value (GAV) ratios improving to 28.8% and 31.1% in recent quarters, down from higher figures in the prior year, indicating some progress in financial stability. However, despite a reduction in net debt to annualized EBITDA ratios, concerns over potential negative operating performance of tenants due to economic headwinds or regulatory changes could significantly affect earnings, leading to a projected ~$0.20 per share earnings headwind. Additionally, the company faces acquisition risk amid these uncertainties, which may hinder its investment pace and overall growth prospects.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Jan 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.